Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis

Journal of Antimicrobial Chemotherapy

Volumn 38, Issue 4, 1996, Pages 641-653

  Meulbroek, Jonathan A ^a   Oleksijew, Anatol ^a   Tanaka, S Ken ^a   Alder, Jeffrey D ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDONE DERIVATIVE; 8 (3 AMINO 1 PYRROLIDINYL) 1 CYCLOPROPYL 7 FLUORO 9 METHYL 4 OXO 3 QUINOLIZINECARBOXYLIC ACID; ANTIINFECTIVE AGENT; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY TRACT INFECTION;

EID: 0029822981     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/38.4.641     Document Type: Article

References (27)

1. Alder, J. & Clement, J. J. (1993). Comparative chemotherapeutic activity of temafloxacin, cefoxitin, clindamycin, imipenem and ampicillin/sulbactam against Bacteroides fragilis in a mouse subcutaneous abscess model. Journal of Antimicrobial Chemotherapy 31, 301-11.
2. Alder, J., Clement, J., Meulbroek, J., Shipkowitz, N., Mitten, M., Jarvis, K. et al. (1995). Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections. Antimicrobial Agents and Chemotherapy 39, 971-5.
3. Alder, J. D., Meulbroek, J. M., Shipkowitz, N. L., Jarvis, K., Mitten, M., Oleksijew, A. et al. (1994). Efficacy of A-86719.1, a novel 2-pyridone gyrase inhibitor, for treatment of systemic, lung, and abscess infections in mice and rats. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F53, p. 109. American Society for Microbiology, Washington, DC.
4. Barry, A. L., Jones, R. N., Thornsberry, C., Ayers, L. W., Gerlach, E. H. & Sommers, H. M. (1984). Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid. Antimicrobial Agents and Chemotherapy 25, 633-7.
5. Chu, D. T., Li, Q., Claiborne, A., Raye-Passarelli, K., Cooper, C., Fung, A. et al. (1994). Synthesis and antibacterial activity of A-86719.1 and related 2-pyridones: a novel series of potent DNA gyrase inhibitors. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F41, p. 108. American Society for Microbiology, Washington, DC.
6. Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M. & Tenover, F. C. (1993). Characterization of glycopeptide-resistant enterococci from U.S. Hospitals. Antimicrobial Agents and Chemotherapy 37, 2311-7.
7. Felmingham, D., Wilson, A. P., Quintana, A. I. & Grüneberg, R. N. (1992). Enterococcus species in urinary tract infections. Clinical Infectious Diseases 15, 295-301.
8. Fernandes, P., Shipkowitz, N. & Bower, R. (1987). Murine models for studying the pathogenesis and treatment of pyelonephritis. Advances in Experimental Medicine and Biology 224, 35-51.
9. Flamm, R. K., Vojtko, C., Chu, D. T., Li, Q., Beyer, J., Hensey, D. et al. (1995). In vitro evaluation of ABT-719, a novel DNA gyrase inhibitor. Antimicrobial Agents and Chemotherapy 39, 964-70.
10. Flamm, R. K., Vojtko, C., Ramer, N., Beyer, J., Li, Q., Chu, D. et al. (1994). Comparative in vitro activity of A-86719.1, a novel bacterial DNA gyrase inhibitor. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, FL, 1994. Abstract F45, p. 109. American Society for Microbiology, Washington, DC.
11. Herman, D. J. & Gerding, D. N. (1991a). Antimicrobial resistance among enterococci. Antimicrobial Agents and Chemotherapy 35, 1-4.
12. Herman, D. J. & Gerding, D. N. (1991b). Screening and treatment of infections caused by resistant enterococci. Antimicrobial Agents and Chemotherapy 35, 215-9.
13. Hoffmann, S. A. & Moellering, R. C. (1987). The enterococcus: "putting the bug in our ears." Annals of Internal Medicine 106, 757-61.
14. Kim, M. J., Weiser, M., Gottschall, S. & Randall, E. L. (1987). Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents. Journal of Clinical Microbiology 25, 787-90.
15. Moellering, R. C. (1992). Emergence of enterococcus as a significant pathogen. Clinical Infectious Diseases 14, 1173-6.
16. Moellering, R. C. (1991). The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. Journal of Antimicrobial Chemotherapy 28, 1-12.
17. Murray, B. E. (1990). The life and times of the Enterococcus. Clinical Microbiology Reviews 3, 46-65.
18. Nakanishi, N., Yoshida, S., Wakebe, H., Inoue, M. & Mitsuhashi, S. (1991). Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis. Antimicrobial Agents and Chemotherapy 35, 1053-9.
19. National Committee for Clinical Laboratory Standards, (1985). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically-Second Edition: Approved Standard M7-A2. NCCLS, Villanova, PA.
20. Nelson, D. & Morris, M. (1984). Hematology and coagulation, basic methodology. In Clinical Diagnosis by Laboratory Methods, 17th edn (Henry, J., Ed.), pp. 578-625. W. B. Saunders and Co., Philadelphia.
21. Perry, J. D., Ford, M. & Gould, F. K. (1994). Susceptibility of enterococci to ciprofloxacin. Journal of Antimicrobial Chemotherapy 34, 297-8.
22. Rao, C. (1973). Linear Statistical Inference and its Applications. Wiley, New York.
23. Sahm, D. F. & Koburov, G. T. (1989). In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy. Antimicrobial Agents and Chemotherapy 33, 71-7.
24. Schaberg, D. R., Dillon, W. I., Terpenning, M. S., Robinson, K. A., Bradley, S. F. & Kauffman, C. A. (1992). Increasing resistance of enterococci to ciprofloxacin. Antimicrobial Agents and Chemotherapy 36, 2533-5.
25. Swanson, R. N., Hardy, D. J., Chu, D. T., Shipkowitz, N. L. & Clement, J. J. (1991). Activity of temafloxacin against respiratory pathogens. Antimicrobial Agents and Chemotherapy 35, 423-9.
26. Whitman, M. S., Pitsakis, P. G., Zausner, A., Livornese, L. L., Osborne, A. J., Johnson, C. C. et al. (1993). Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy 37, 2069-73.
27. Zervos, M. J., Bacon, A. E., Patterson, J. E., Schaberg, D. R. & Kauffman, C. A. (1988). Enterococcal superinfections in patients treated with ciprofloxacin. Journal of Antimicrobial Chemotherapy 21, 113-5.